Experimental models of torsades de pointes

Area of Science:

• Cardiology
• Pharmacology
• Electrophysiology

Background:

• Torsades de pointes (TdP) is a rare but life-threatening ventricular tachycardia associated with QT interval prolongation.
• Reproducing TdP in animal models is difficult, hindering the study of its mechanisms and the proarrhythmic effects of drugs.
• Existing models include morphological, early afterdepolarization (EAD)-related, and pharmacological approaches, each with limitations.

Purpose of the Study:

• To review existing animal models for Torsades de pointes.
• To evaluate the efficacy of a novel conscious dog model in reproducing TdP.
• To assess the utility of this model for drug comparison and mechanistic studies.

Main Methods:

• Review of literature on TdP animal models (morphological, EAD-related, pharmacological).
• Development and testing of a conscious dog model with induced bradycardia and hypokalemia.
• Administration of various antiarrhythmic drugs (quinidine, sotalol, flecainide, propranolol, lidocaine) to assess TdP induction.

Main Results:

• Existing models have limitations in fully replicating TdP conditions like long QT and bradycardia.
• The conscious bradycardic and hypokalemic dog model successfully induced TdP with quinidine and sotalol, but not flecainide, propranolol, or lidocaine.
• The model demonstrated sensitivity to high-rate pacing and magnesium, consistent with TdP pathophysiology.

Conclusions:

• The conscious bradycardic and hypokalemic dog model is a valuable tool for studying TdP mechanisms.
• This model is suitable for qualitative drug comparisons regarding QT-dependent proarrhythmias.
• Further validation is needed to assess its relevance for non-antiarrhythmic agents.